Literature DB >> 10340529

Effect of the dopaminergic neurotoxin MPTP on cocaine-induced locomotor sensitization.

Y Itzhak1, J L Martin, M D Black, S F Ali.   

Abstract

The blockade of dopamine (DA) uptake via the dopamine transporter (DAT) in the nucleus accumbens (NAC) and striatum by cocaine has a major role in the reinforcing and psychomotor stimulating effects of the drug. Here we investigated the effect of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the expression and induction of sensitization to the locomotor stimulating effect of cocaine. MPTP (20 mg/kg x 4) caused 72 and 76% depletion of DAT sites in the NAC and striatum, respectively, in C57BL/6 mice. The magnitude of this depletion 3 and 19 days after MPTP administration was the same. To determine the effect of MPTP on the expression of the sensitized response to cocaine, cocaine-experienced mice (20 mg/kg for 5 days) received MPTP 3 days before a challenge cocaine injection was given on day 15. Cocaine/MPTP mice were significantly more sensitive to the challenge cocaine injection than the cocaine/saline-pretreated mice. To determine whether depletion of NAC and striatal DAT affects the induction of sensitization to cocaine, mice were pretreated with MPTP 3 days before the administration of cocaine (20 mg/kg for 5 days). The magnitude of the sensitized response of MPTP/cocaine-pretreated mice to cocaine challenge was the same as the sensitized response of mice treated with saline/cocaine, while the number of DAT binding sites in the MPTP/cocaine group was significantly lower than the saline/cocaine group. The present study indicates that MPTP exacerbates the expression of locomotor sensitization to cocaine, but it had no effect on the induction of sensitization. We conclude that the expression, but not the induction, of locomotor sensitization to cocaine may be dependent on the level of DAT binding sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340529     DOI: 10.1016/s0091-3057(98)00246-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

1.  Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice.

Authors:  Yossef Itzhak; Syed F Ali; Cindy N Achat; Karen L Anderson
Journal:  Psychopharmacology (Berl)       Date:  2003-02-18       Impact factor: 4.530

2.  MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine.

Authors:  Eduard R Mingazov; Gulnara R Khakimova; Elena A Kozina; Alexei E Medvedev; Olga A Buneeva; Ara S Bazyan; Michael V Ugrumov
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

3.  Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson's disease model mice.

Authors:  Kazuaki Handa; Shuichi Kiyohara; Tomoyuki Yamakawa; Koji Ishikawa; Masahiro Hosonuma; Nobuhiro Sakai; Akiko Karakawa; Masahiro Chatani; Mayumi Tsuji; Katsunori Inagaki; Yuji Kiuchi; Masamichi Takami; Takako Negishi-Koga
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

4.  Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism.

Authors:  Yusuf S Althobaiti; Atiah Almalki; Hashem Alsaab; Walaa Alsanie; Ahmed Gaber; Qasim Alhadidi; Ana Maria Gregio Hardy; Abdulrahman Nasr; Omar Alzahrani; Creed M Stary; Zahoor A Shah
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

5.  Factors regulating serine racemase and d-amino acid oxidase expression in the mouse striatum.

Authors:  Shunsuke Takagi; Darrick T Balu; Joseph T Coyle
Journal:  Brain Res       Date:  2020-11-07       Impact factor: 3.252

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.